6NOVEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIt is a known fact that bioanalytical techniques create improvements in optimization and process control. However, progress in the development and implementation of bioprocessing-related assays and analytical instrumentation has not kept up with the pharma industry's demands. Increasing productivity pressures are forcing biopharmaceutical manufacturers and CMOs to do more with less, in addition to the increased need by regulatory agencies for better data and documentation on product quality.To that end, the industry is slowly adopting analytical techniques like process analytical technology (PAT), a method that enables continuous and real-time quality assurance to ensure consistently high product quality and performance, batch after batch. PAT provides the pharmaceutical industry a framework for revolutionizing its R&D and manufacturing businesses to produce value for both themselves and patients. Another concept that will soon see the light of day in the pharma industry is AI in analytical testing. Bioanalytics presents unique challenges not only in the form of high-volume data analysis but also in the amount of disparate data that needs to be linked and contextualized across multiple data sets in assay development, validation, and sample analysis. That being said, the demand for analytical testing support will continue to grow within the pharmaceutical industry as biopharmaceutical companies seek to maximize the use of internal resources for highly complex and proprietary activities. In this edition of Pharma Tech Outlook, we bring you the story of some of the most successful bioanalytical service companies that are leveraging innovative technologies to facilitate the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the partner that best fits your analytical requirements.Let us know your thoughts!A Future Powered by AICopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 25 - 2020, Vol 06 - Issue 26 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerChris LynnEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >